HIV Infection Clinical Trials

689 clinical trials for HIV Infection across international registries, including 23 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission — RECRUITING · PHASE1
• Optimization of Antiretroviral Therapy in Patients With AIDS-Related Lymphoma — RECRUITING · NA
• Colchicine to Reduce Coronary Artery Inflammation in People With HIV — RECRUITING · PHASE2
• Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma — RECRUITING · PHASE1
• Effectiveness and Safety of Darunavir/Cobicistat Plus Lamivudine Compared With Darunavir/Cobicistat Plus Tenofovir Alafenamide/Emtricitabine in Virologically Suppressed People Living With HIV at 24 and 48 Weeks of Follow-up — RECRUITING · PHASE4
• Dental Management of Patients With HIV in Pays de la Loire — RECRUITING
• Impact of Behavior Modification Interventions and Lung Cancer Screening on Smoking Cessation in People Living With HIV: A Feasibility Study — RECRUITING · NA
• Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers — RECRUITING
• Menopausal HT for Women Living With HIV (HoT) — RECRUITING · PHASE4
• Reducing Hazardous Alcohol Use and Optimizing Treatment as Prevention Among Men Living With HIV in Risk Environments — RECRUITING · NA
• Characteristics of Immunity in Gut Mucosa, Spinal Fluid, Lymph Node and Blood of HIV Negative Thais and Thais With HIV Infection — RECRUITING · NA
• Zn Supplementation in HIV Immunological Non Responders — RECRUITING · NA
• the ANRS CO21 " Extreme " Cohort (CODEX) — RECRUITING · NA
• #AWARE.HIV Europe: Supporting Healthcare Professionals to Find Undiagnosed HIV in European Hospitals: An Effectiveness-implementation Trial. — RECRUITING · NA
• Multiplo Tp/HIV Self-Test — RECRUITING · NA
• HIV+ Deceased Donor Heart Transplant Study for HIV+ Recipients — RECRUITING · NA
• Cardiovascular Risk in Children With Chronic Conditions Study — RECRUITING
• The Role of the Gastrointestinal-associated Lymphoid Tissue in the Cure of HIV Infection — RECRUITING · NA
• Safety, Tolerability and Effectiveness of DTG/3TC vs BIC/TAF/FTC in PWH Without Antiretroviral Experience — RECRUITING · PHASE4
• Effectiveness and Safety of Darunavir/Cobicistat Plus Lamivudine Versus Darunavir/Cobicistat Plus Tenofovir/Emtricitabine in Virologically Suppressed HIV-1-positive Individuals in Mexico — RECRUITING · PHASE4
• PrEPared to Choose (PtC) is an Implementation Study of the Delivery of Cabotegravir Long-acting, an Injectable Pre-exposure Prophylaxis (PrEP) Option for HIV Prevention. Injectable PrEP Will be Offered Alongside Oral and Vaginal Ring PrEP From Within a Real-world Context in Cape Town, South Africa. — RECRUITING
• Clinical Trial to Evaluate the Efficacy and Safety of Codivir® in Addition to Standard Antiretroviral Treatment for HIV Infection in Antiretroviral-naïve Participants — RECRUITING · PHASE2
• Good-first: B/F/TAF As First-line ART — RECRUITING
• HIV virus decrease in semen and rectum in patients HIV+ men, who starts treatment with dolutegravir plus lamivudine compared to Bictegravir/FTC/TAF — ACTIVE_NOT_RECRUITING · PHASE4
• Evaluation of the benefits of immediate versus conventional treatment with BIC / FTC / TAF in naive patients with type 1 HIV infection — ACTIVE_NOT_RECRUITING · PHASE4
• Study of pharmacological characteristics of antiretroviral drugs atazanavir/ritonavir and maraviroc in stable HIV-positive patients — ACTIVE_NOT_RECRUITING · PHASE3
• A Multicenter, Double-Blind, Randomized, Active-Controlled Study to Evaluate the Safety and Antiretroviral Activity of MK-0518 Versus KALETRA™ in HIV-Infected Patients Switched from a Stable KALETRA™-Based Regimen - Study A Estudio Multicéntrico, doble ciego, randomizado y controlado con comparador activo, para evaluar la Seguridad y la Eficacia Antiretroviral del MK0518 frente a KALETRA™ en pacientes infectados con VIH y en tratamiento estable con KALETRA™ a los que se les cambia de tratamiento. — TERMINATED · PHASE3
• PRe-exposure Option for reducing HIV in the UK: an open-label randomisation to immediate or Deferred daily Truvada for HIV negative gay men — COMPLETED · PHASE4
• The influence of Raltegravir (MK_0518) on the pharmacokinetics of single-dose Lamotrigine in healthy male subjects (GRANOLA) — COMPLETED · PHASE4
• Tolerance and immunological response in HIV seropositive individuals after NR100063 supplementation — ACTIVE_NOT_RECRUITING · PHASE2
• GW433908 Expanded Access Program for HIV infected subjects non responding or intolerant to the previous antiretroviral treatments — TERMINATED · PHASE3
• A pilot, open label, randomised clinical trial assessing the 12 week immunological response in HIV-1 failing subjects receiving monotherapy with emtricitabine 200 mg once a day or emtricitabine 200 mg once a week or lamivudine 300 mg once a day — COMPLETED · PHASE2
• DUALIS A prospective, multicenter, randomized, open-label trial to assess the safety, tolerability and efficacy of dual therapy with boosted Darunavir + Dolutegravir when switching from standard of care ART in HIV-patients with sustained virological suppression — TERMINATED · PHASE3
• CV risk in HIV patients switching from a boosted PI to DTG — COMPLETED · PHASE4
• A study to find out whether maraviroc given once daily is as effective as Truvada given once daily in treating HIV-infected patients never previously treated with maraviroc. — COMPLETED · PHASE3
• SSAT046 Addition of Maraviroc to monotherapy Darunavir/Ritonavir study — COMPLETED · PHASE4
• Safety and Effect of the Histone Deacetylase Inhibitor Romidepsin and the Therapeutic Vaccine Vacc-4x for Reduction of the Latent HIV Reservoir — COMPLETED · PHASE2
• Strategic long term, immunologically driven treatment interruptions in previously naive patients starting HAART: a controlled, randomized, multicenter study — ACTIVE_NOT_RECRUITING · PHASE3
• Ensayo para evaluar la eficacia, seguridad y tolerabilidad, de una estrategia de simplificacion temprana a Trizivir, en pacientes con supresion virologica tras tratamiento antiretroviral con Combivir mas Lopinavir/Ritonavir (Kaletra). — ACTIVE_NOT_RECRUITING · PHASE4
• Study to test a new drug GSK1349572 for HIV patients with raltegravir or elvitegravir failure — COMPLETED · PHASE3
• A Multicenter, Randomized, Double-Blind, Phase 2b Trial to Determine The Efficacy, Tolerability And Safety Of 3 Dose Regimens Of RDEA806 and Open-Label Efavirenz as Active Control in HIV 1-Infected, Antiretroviral Naïve Subjects — TERMINATED · PHASE2
• A Phase IIIB, Randomized, Open-Label, Multicenter Study of the Safety and Efficacy of GW433908 700mg BID plus ritonavir 100mg BID Versus Lopinavir/ritonavir 400mg/100mg BID when Administered in Combination with the Abacavir/Lamivudine 600mg/300mg Fixed-Dose Combination Tablet QD in Antiretroviral-Nave HIV-1 Infected Adults Over 48 Weeks — COMPLETED · PHASE3
• Screening Algorithms for Cervical and Anal High-Grade Squamous Intraepithelial Lesions in People With HIV in Mexico and Puerto Rico — COMPLETED · NA
• Acceptability, Quality of Care, Patient Satisfaction, and Cost-effectiveness of Monitoring Provided by Nurses or Physicians for People Using HIV Pre-exposure Prophylaxis — NOT_YET_RECRUITING · NA
• A Phase 3 Open-label Rollover Clinical Study of Doravirine/Islatravir (DOR/ISL) Once daily for the Treatment of HIV-1 Infection in Participants Who Previously Received DOR/ISL in a Phase 2 or Phase 3 DOR/ISL Clinical Study — TERMINATED · PHASE3
• Safety, Tolerability, and Efficacy of IL-15 Superagonist (N-803) With and Without Combination Broadly Neutralizing Antibodies to Induce HIV-1 Control During Analytic Treatment Interruption — ACTIVE_NOT_RECRUITING · PHASE1
• MAPS PrEP Van Study — COMPLETED · PHASE4
• Antiretroviral Adherence Evaluation in HIV Pregnant and Postpartum Women — COMPLETED
• HIV Disclosure and Medication Adherence, a Pilot Study — COMPLETED
• Tenofovir, Emtricitabine and Efavirenz Late Switch to a Single Pill: Patients' Opinion Survey — COMPLETED

Refine this search